Roderick Mackenzie on TransCelerate
From Rod MacKenzie's Leadership Lens for TransCelerate's 10-Year Anniversary · · TransCelerate BioPharma
“For the past 10 years, TransCelerate has worked to improve R&D by partnering with stakeholders across the ecosystem to transform the important insights and experiences and perspectives of its members into sustainable industry change.”
On , Roderick Mackenzie, Executive Vice President & Chief Commercial Officer at TRANSOCEAN LTD, spoke about TransCelerate during Rod MacKenzie's Leadership Lens for TransCelerate's 10-Year Anniversary on TransCelerate BioPharma.
About Roderick Mackenzie
In a September 2022 video marking TransCelerate's 10-year anniversary, Rod MacKenzie, then former Chief Development Officer of Pfizer and immediate past chair of the TransCelerate board, stated that the COVID-19 pandemic "forced us to think differently and challenge every one of our convictions about drug discovery and development." He attributed the resulting "breakthrough vaccines and medicines with unprecedented speed and quality" to "remarkable cross-sector collaboration." MacKenzie said that if TransCelerate had not existed prior to 2020, a similar organization would have had to be created from scratch to address the public health need. MacKenzie described TransCelerate as having worked over the past decade to improve R&D by partnering with stakeholders to turn member insights into "sustainable industry change." He said that as Chief Development Officer he had a "front row seat" for Pfizer's COVID-19 vaccine and oral antiviral development, which he described as setting "a new standard for the future of drug development." MacKenzie stated that the industry "cannot go back to the way things were before" and emphasized the importance of building on pandemic-era learnings to make trials "more equitable" and to accelerate delivery of medicines. He called TransCelerate "a key resource" for sharing learnings and addressing challenges such as access and diversity in trials.